✦ LIBER ✦

Homoharringtonine in combination with cytarabine and aclarubicin in the treatment of refractory/relapsed acute myeloid leukemia: a single-center experience

✍ Scribed by Wenjuan Yu, Liping Mao, Jiejing Qian, Wenbin Qian, Haitao Meng…

Book ID: 120775816
Publisher: Springer
Year: 2013
Tongue: English
Weight: 280 KB
Volume: 92
Category: Article
ISSN: 0939-5555
DOI: 10.1007/s00277-013-1758-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

FLAG-IDA in the treatment of refractory/

FLAG-IDA in the treatment of refractory/relapsed acute myeloid leukemia: single-center experience

✍ D. Pastore; G. Specchia; P. Carluccio; A. Liso; A. Mestice; R. Rizzi; G. Greco; 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 116 KB

Combination chemotherapy with low-dose c

Combination chemotherapy with low-dose cytarabine, homoharringtonine, and granulocyte colony-stimulating factor priming in patients with relapsed or refractory acute myeloid leukemia

✍ Wang-Gang Zhang; Fang-Xia Wang; Yin-Xia Chen; Xin-Mei Cao; Ai-Li He; Jie Liu; Xi 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB 👁 2 views

## Abstract As sensitization of leukemic cells with granulocyte colony‐stimulating factor (G‐csf) can enhance the cytotoxicity of chemotherapy in acute myeloid leukemia (AML), a pilot study was conducted in order to evaluate the effect of G‐csf priming combined with low‐dose chemotherapy in patient

Low dose of homoharringtonine and cytara

Low dose of homoharringtonine and cytarabine combined with granulocyte colony-stimulating factor priming on the outcome of relapsed or refractory acute myeloid leukemia

✍ Liu-Fang Gu; Wang-Gang Zhang; Fang-Xia Wang; Xing-Mei Cao; Yin-Xia Chen; Ai-Li H 📂 Article 📅 2010 🏛 Springer-Verlag 🌐 English ⚖ 230 KB

Sequential administration of irinotecan

Sequential administration of irinotecan and cytarabine in the treatment of relapsed and refractory acute myeloid leukemia

✍ Hans Minderman; Kieran L. O’Loughlin; Patrick F. Smith; Lakshmi Pendyala; Willia 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 430 KB

Etoposide in combination with low-dose C

Etoposide in combination with low-dose CAG (cytarabine, aclarubicin, G-CSF) for the treatment of relapsed or refractory acute myeloid leukemia: A multicenter, randomized control trial in southwest China

✍ Zhang, Xi; Li, Yunlong; Zhang, Yanqi; Chen, Xinghua; Zhang, Cheng; Gao, Li; Kong 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 962 KB

Increasing the dose of aclarubicin in lo

Increasing the dose of aclarubicin in low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor (CAG regimen) can safely and effectively treat relapsed or refractory acute myeloid leukemia

✍ Liu, Limin; Zhang, Yanming; Jin, Zhengming; Zhang, Xingxia; Zhao, Guangsheng; Si 📂 Article 📅 2014 🏛 Carden Jennings Publishing 🌐 English ⚖ 322 KB